QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats

Congyang Dinga National Clinical Drug Monitoring Center, Hebei General Hospital, Shijiazhuang, ChinaView further author information

Yajing Lia National Clinical Drug Monitoring Center, Hebei General Hospital, Shijiazhuang, ChinaView further author information

Xiao Lia National Clinical Drug Monitoring Center, Hebei General Hospital, Shijiazhuang, ChinaView further author information

Lu Mengb Department of Pharmacy, The Second Hospital of Shijiazhuang, Shijiazhuang, ChinaView further author information

Ran Fuc Graduate School, Hebei Medical University, Shijiazhuang, ChinaView further author information

Xiaonan Wangc Graduate School, Hebei Medical University, Shijiazhuang, ChinaView further author information

Ying Lia National Clinical Drug Monitoring Center, Hebei General Hospital, Shijiazhuang, ChinaView further author information

Yinling Maa National Clinical Drug Monitoring Center, Hebei General Hospital, Shijiazhuang, ChinaView further author information

Zhanjun Donga National Clinical Drug Monitoring Center, Hebei General Hospital, Shijiazhuang, ChinaCorrespondence[email protected]

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.